SCHEMBL23837317

SCHEMBL23837317

CCOC(=O)c1c(F)ccc2c1OB(N=O)[C@@H](NC(=O)CC)C2

nearest known ligand 0.34

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ RAB9A P51151 2/20 0.34
▸ CYP11B2 P19099 5/20 0.33
▸ CYP11B1 P15538 3/20 0.33
▸ KDM4E B2RXH2 1/20 0.33
▸ HTT P42858 1/20 0.33
▸ L3MBTL1 Q9Y468 1/20 0.33
▸ TP53 P04637 1/20 0.33
▸ MAPT P10636 1/20 0.33
▸ CXCR2 P25025 2/20 0.32
▸ CXCR4 P61073 2/20 0.32
▸ THRB P10828 1/20 0.32
▸ MTNR1A P48039 1/20 0.32
▸ MTNR1B P49286 1/20 0.32
▸ MEN1 O00255 3/20 0.32
▸ KMT2A Q03164 3/20 0.32
▸ ALDH1A1 P00352 1/20 0.32
▸ FDFT1 P37268 1/20 0.31
▸ GRM6 O15303 1/20 0.31
▸ PRKCZ Q05513 1/20 0.31
▸ XBP1 P17861 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23837293 0.91 HTT (0.33) KDM4EHTTL3MBTL1TP53MAPT
SCHEMBL17347781 0.88 RAB9A (0.36) RAB9ACYP11B2CYP11B1KDM4EHTT
SCHEMBL23129947 0.88 RAB9A (0.36) RAB9ACYP11B2CYP11B1KDM4EHTT
SCHEMBL23130281 0.80 MTNR1A (0.36) RAB9AKDM4EHTTL3MBTL1TP53
SCHEMBL17347697 0.80 MTNR1A (0.36) RAB9AKDM4EHTTL3MBTL1TP53
SCHEMBL23837315 0.79 MTNR1A (0.38) HTTMAPTMTNR1AMTNR1B
SCHEMBL17347748 0.79 HTT (0.35) RAB9AKDM4EHTTL3MBTL1TP53
SCHEMBL23130009 0.79 HTT (0.35) RAB9AKDM4EHTTL3MBTL1TP53
SCHEMBL23837505 0.78 MTNR1A (0.32) CYP11B2CYP11B1MTNR1AMTNR1B
SCHEMBL19663664 0.77 ALDH1A1 (0.34) RAB9AKDM4EMAPTMTNR1AMTNR1B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3882252-A1 BETA-LACTAMASE INHIBITORS Venatorx Pharmaceuticals, Inc. (US) 2021-09-22 — — EP disclosed
Send feedback